# Observational Lymphoma, B-Cell studies recruiting: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials that are observational for Lymphoma, B-Cell that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Lymphoma, B-Cell studies: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/lymphoma-b-cell

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07888530 | Non-Interventional Study of Ranicabtagene Autoleucel Injection for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | Hrain Biotechnology Co., Ltd. | Observational | Not yet recruiting | B-Cell Non-Hodgkin Lymphoma (NHL) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888530) |
| October 20, 2026 | NCT07882732 | RPM Signals in Outpatient CAR T Therapy | Current Health | Observational | Not yet recruiting | Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome, B-Cell Lymphoma, Chronic Lymphocytic... | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882732) |
| October 20, 2026 | NCT07882576 | A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma | AstraZeneca | Observational | Not yet recruiting | Lymphoma, B-Cell | 532 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882576) |
| August 17, 2026 | NCT07767799 | Biological Analysis of MABs in NHL in a Translational Prospective Observational Study Within Italian Clinical Practice | Fondazione Italiana Linfomi - ETS | Observational | Not yet recruiting | B-Cell Non-Hodgkin Lymphoma (NHL) | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07767799) |
| July 20, 2026 | NCT07713511 | INfections in Patients Treated With CAR-T | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Not yet recruiting | Relapsed Multiple Myeloma, Refractory Multiple Myeloma, B-Cell Non-Hodgkin Lymphoma, Bloodstream Infections, CAR-T Cell... | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713511) |
| July 10, 2026 | NCT07695896 | Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma | Sponsor not shown (see the record) | Observational | Not yet recruiting | Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07695896) |
| June 17, 2026 | NCT07652580 | Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma | Henry M. Jackson Foundation for the Advancement of Military Medicine | Observational | Recruiting | Non-Hodgkin Lymphoma, Lymphoma Non-Hodgkin, B-cell Lymphoma, Immune Dysregulation | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652580) |
| February 4, 2026 | NCT07385612 | Research for Resistance Factors in the Treatment of Lymphoid Hemopathy | Nantes University Hospital | Observational | Not yet recruiting | MATURE B-CELL LYMPHOIDS | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07385612) |
| September 30, 2025 | NCT07198373 | Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell... | Beijing GoBroad Hospital | Observational | Not yet recruiting | B Cell Lymphoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07198373) |
| February 26, 2025 | NCT06847529 | Systemic Inflammatory Markers in B-cell Neoplasm | Assiut University | Observational | Not yet recruiting | B-cell Neoplasm | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06847529) |
| January 28, 2025 | NCT06796517 | Immunotherapy in Lymphoma | Sponsor not shown (see the record) | Observational | Recruiting | Relapsed/refractory High Grade B Cell Lymphoma, High Grade B-cell Lymphoma, Diffuse Large B Cell Lymphoma Relapsed... | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796517) |
| December 6, 2024 | NCT06721598 | An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders | National Research Center for Hematology, Russia | Observational | Not yet recruiting | Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06721598) |
| August 27, 2024 | NCT06573099 | A Real-World Study on Extranodal Lymphoma | Ruijin Hospital | Observational | Not yet recruiting | Lymphoma, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Extranodal Lymphoma, Diffuse Large B Cell Lymphoma | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06573099) |
| June 3, 2024 | NCT06439173 | Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of... | Instituto de Investigación Biomédica de Salamanca | Observational | Recruiting | Diffuse Large B Cell Lymphoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06439173) |
| April 8, 2024 | NCT06350994 | Early Assessment of Cardiac Function After Treatment With CAR-T Cells | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Car T- Cell, Hematologic Malignancy, Acute Lymphoblastic Leukemia, Lymphoma, B-Cell, Multiple Myeloma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06350994) |
| February 5, 2024 | NCT06241729 | Prospective Observational Study of Diffuse Large-cell B Lymphoma | Grand Hôpital de Charleroi | Observational | Recruiting | Lymphoma, B-Cell | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06241729) |
| November 21, 2023 | NCT06142188 | Relmacabtagene Autoleucel in Hematologic Malignancies | Shanghai Ming Ju Biotechnology Co., Ltd. | Observational | Not yet recruiting | Lymphoma, B-Cell, Large B-cell Lymphoma, Follicular Lymphoma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06142188) |
| November 14, 2023 | NCT06131801 | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution | Children's Hospital Medical Center, Cincinnati | Observational | Recruiting | Hematologic Malignancy, Leukemia, Lymphoma, Acute Lymphocytic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06131801) |
| March 9, 2020 | NCT04300998 | Study of CAR-T Therapy in Older Patients | Memorial Sloan Kettering Cancer Center | Observational | Recruiting | Lymphoma, Refractory B-Cell Lymphoma, Lymphoma, B-Cell, DLBCL NOS, High-grade B-cell Lymphoma, Multiple Myeloma | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04300998) |
| December 18, 2017 | NCT03375619 | Long-term Follow-up Study of Patients Receiving CAR-T Cells | Medical College of Wisconsin | Observational | Recruiting | Chronic Lymphocytic Leukemia, Lymphomas Non-Hodgkin's B-Cell, Lymphoma, Small Lymphocytic, Mantle Cell Lymphoma... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03375619) |
| February 29, 2008 | NCT00626496 | Family Study of Lymphoproliferative Disorders | Mayo Clinic | Observational | Recruiting | Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Monoclonal B-Cell Lymphocytosis... | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00626496) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Beijing GoBroad Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Hrain Biotechnology Co., Ltd. | 1 |
| Mayo Clinic | 1 |
| Current Health | 1 |
| Assiut University | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| National Research Center for Hematology, Russia | 1 |
| Instituto de Investigación Biomédica de Salamanca | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Nantes University Hospital | 1 |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| Shanghai Ming Ju Biotechnology Co., Ltd. | 1 |
| Grand Hôpital de Charleroi | 1 |
| Medical College of Wisconsin | 1 |
| Ruijin Hospital | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 5 |
| Italy | 2 |
| France | 2 |
| China | 2 |
| Egypt | 1 |
| Brazil | 1 |
| Russia | 1 |
| Spain | 1 |
| South Korea | 1 |
| Belgium | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Medical service organizations in the United States](https://specstream.ai/data/businesses/medical-service-organizations/united-states)
- [Water delivery companies in the United States](https://specstream.ai/data/businesses/water-delivery-companies/united-states)
- [Empanada restaurants in the United States](https://specstream.ai/data/businesses/empanada-restaurants/united-states)
- [Pediatric endocrinology practices in the United States](https://specstream.ai/data/businesses/pediatric-endocrinology-practices/united-states)
- [Auto insurance agencies in the United States](https://specstream.ai/data/businesses/auto-insurance-agencies/united-states)
- [Generator installation repair companies in the United States](https://specstream.ai/data/businesses/generator-installation-repair-companies/united-states)
